Literature DB >> 8601545

Fungal complications of transplantation: diagnosis, treatment and prevention.

D W Warnock1.   

Abstract

Invasive fungal infection remains a major problem in transplant recipients. The commonest causes of infection are Candida, and Aspergillus spp., although a growing number of other organisms (including species of Fusarium and Trichosporon) have been reported to cause infection in neutropenic bone marrow transplant recipients. The clinical manifestations of these infections are described and methods of diagnosis are discussed. As in other groups of immunocompromised patients, the diagnosis is often difficult to establish, but transplant recipients who are given empirical treatment with amphotericin B have increased rates of survival. The roles of lipid-associated forms of amphotericin B and of the triazole compounds, itraconazole and fluconazole, in the treatment and prevention of fungal infection are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8601545     DOI: 10.1093/jac/36.suppl_b.73

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Economic evaluation of intravenous itraconazole for presumed systemic fungal infections in neutropenic patients in Korea.

Authors:  K Moeremans; L Annemans; Ji-So Ryu; Kang-Won Choe; Wan-Shik Shine
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 3.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  In vitro activity of A-192411.29, a novel antifungal lipopeptide.

Authors:  A M Nilius; P M Raney; D M Hensey-Rudloff; W Wang; Q Li; R K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

5.  Gastric mucormycosis due to Rhizopus oryzae in a renal transplant recipient.

Authors:  S Winkler; S Susani; B Willinger; R Apsner; A R Rosenkranz; R Pötzi; G A Berlakovich; E Pohanka
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

6.  Postmortem analysis of invasive aspergillosis in a tertiary care hospital.

Authors:  M Vogeser; A Haas; D Aust; G Ruckdeschel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.